If the K4E, Y69H and D83V mutations promote lymphoma development by decreasing the capacity of MEF2B to activate transcription, the most parsimonious explanation for how other MEF2B mutations contribute to lymphoma development would be that they also decrease MEF2B's capacity to activate transcription. This evidence concerns the gene MEF2B and lymphoma.